Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM

被引:44
作者
Coppola, G [1 ]
Corrado, E
Muratori, I
Tantillo, R
Vitale, G
Lo Coco, L
Novo, S
机构
[1] Univ Palermo, Dept Internal Med Cardiovasc & Nephro Urol Dis, Chair Cardiovasc Dis, Palermo, Italy
[2] Univ Palermo, Dept Clin Med & Emerging Dis, Chair Internal Med, Palermo, Italy
关键词
C-reactive protein; diabetes mellitus; acute myocardial infarction;
D O I
10.1016/j.ijcard.2004.12.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To evaluate the predictive role of hs-CRP and fibrinogen for cardio- and cerebrovascular events in a population of patients with type 2 diabetes. Methods: We studied 156 patients with type 2 diabetes, mean age 66+10 years, and 156 sex and age matched control subjects. Patients underwent physical examination, EKG, measurement of body mass index and blood pressure. A blood sample was drawn to evaluate glycaemia, total and HDL/LDL cholesterol, triglycerides, high sensitive C-reactive protein (hs-CRP), fibrinogen. Finally, patients underwent an ecocolordoppler examination of the common carotid arteries until the bifurcation. In a follow-up of 5 +/- 1.2 years we evaluated the following events: transient ischemic attack, ischemic stroke, stable or unstable angina, acute myocardial infarction, critical limb ischemia and cardiovascular death. Results: During the follow-up the prevalence of fatal (p < 0.05) and non fatal events (p < 0.0001) was higher in patients with diabetes in comparison with controls. The variables independently associated with non fatal events were: fibrinogen (p < 0.0001), presence of asymptomatic carotid lesion (p < 0.005), obesity (p < 0.05) and plasma levels of hs-CRP (p < 0.05), while fibrinogen (p < 0.001) and age were (p < 0.05) independently associated with fatal events. Conclusion: Our data show that in patients with diabetes mellitus, that in the follow-up the presence of high plasma levels of hs-CRP and fibrinogen are predictive for fatal or non fatal events. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 31 条
[11]   C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men -: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 [J].
Koenig, W ;
Sund, M ;
Fröhlich, M ;
Fischer, HG ;
Löwel, H ;
Döring, A ;
Hutchinson, WL ;
Pepys, MB .
CIRCULATION, 1999, 99 (02) :237-242
[12]   FIBRINOGEN AND SILENT ATHEROSCLEROSIS IN SUBJECTS WITH CARDIOVASCULAR RISK-FACTORS [J].
LEVENSON, J ;
GIRAL, P ;
RAZAVIAN, M ;
GARIEPY, J ;
SIMON, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1263-1268
[13]   Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins -: A long-term cohort study [J].
Lind, P ;
Hedblad, B ;
Stavenow, L ;
Janzon, L ;
Eriksson, KF ;
Lindgärde, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) :452-458
[14]   2003 European society of hypertension -: European Society of Cardiology guidelines for the management of arterial hypertension [J].
Mancia, G ;
Rosei, EA ;
Cifkova, R ;
DeBacker, G ;
Erdine, S ;
Fagard, R ;
Farsang, C ;
Heagerty, AM ;
Kawecka-Jaszcs, K ;
Kiowski, W ;
Kjeldsen, S ;
Lüscher, T ;
McInnes, G ;
Mallion, JM ;
Brien, EO ;
Poulter, NR ;
Priori, SG ;
Rahn, KH ;
Rodicio, JL ;
Ruilope, LM ;
Safar, M ;
Staessen, JA ;
van Zwieten, P ;
Waeber, B ;
Williams, B ;
Zanchetti, A ;
Zannad, F .
JOURNAL OF HYPERTENSION, 2003, 21 (06) :1011-1053
[15]   MICROPARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY FOR HUMAN C-REACTIVE PROTEIN [J].
MONTAGNE, P ;
LAROCHE, P ;
CUILLIERE, ML ;
VARCIN, P ;
PAU, B ;
DUHEILLE, J .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1992, 6 (01) :24-29
[16]  
OKANO RH, 2002, DIABETES CARE, V25, P1432
[17]   INTIMAL PLUS MEDIAL THICKNESS OF THE ARTERIAL-WALL - A DIRECT MEASUREMENT WITH ULTRASOUND IMAGING [J].
PIGNOLI, P ;
TREMOLI, E ;
POLI, A ;
ORESTE, P ;
PAOLETTI, R .
CIRCULATION, 1986, 74 (06) :1399-1406
[18]   C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus [J].
Pradhan, AD ;
Manson, JE ;
Rifai, N ;
Buring, JE ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (03) :327-334
[19]   Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J].
Ridker, PM ;
Cushman, M ;
Stampfer, MJ ;
Tracy, RP ;
Hennekens, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :973-979
[20]   Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. [J].
Ridker, PM ;
Rifai, N ;
Rose, L ;
Buring, JE ;
Cook, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) :1557-1565